Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	136	112	111	58	28	-
Market Cap Growth	4.85%	0.65%	90.50%	111.19%	-	-
Enterprise Value	139	102	96	43	8	-
Last Close Price	3.87	3.17	4.16	2.69	2.30	-
Debt / Equity Ratio	0.00	0.00	11.71	1.25	0.52	-0.59
Quick Ratio	12.59	10.74	1.01	6.00	13.38	0.03
Current Ratio	13.00	11.10	1.02	6.08	13.49	0.05
Return on Equity (ROE)	-116.77%	-157.31%	-715.19%	-178.04%	-	-
Return on Assets (ROA)	-52.06%	-61.14%	-88.37%	-52.20%	-68.51%	-59.25%
Return on Capital (ROIC)	-62.63%	-78.03%	-126.40%	-58.41%	-110.75%	-
Buyback Yield / Dilution	-37.52%	-40.52%	-25.21%	-55.45%	-102.75%	-0.01%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q